Who owns ANAPTYSBIO, INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ANAB from SEC Form 13F filings across 229 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 229 institutions disclosed 30.8M shares of ANAPTYSBIO, INC worth $1.55B — about 103.3% of shares outstanding; the largest disclosed holder is EcoR1 Capital, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
229
13F holders
$1.55B
value, 2026 filers
103.3%
of shares outstanding (30.8M sh)
54
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ANAB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | EcoR1 Capital, LLC | 7.9M | $396.1M | 17.6% | 26.4% | 0.0% |
| 2 | BlackRock, Inc. | 1.9M | $95.1M | 0.0% | 6.3% | +2.6% |
| 3 | TANG CAPITAL MANAGEMENT LLC | 1.5M | $74.1M | 3.4% | 4.9% | +10.8% |
| 4 | STATE STREET CORP | 1.1M | $57.6M | 0.0% | 3.8% | -10.9% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 909,946 | $45.7M | 0.0% | 3% | +0.4% |
| 6 | GOLDMAN SACHS GROUP INC | 850,343 | $42.7M | 0.0% | 2.8% | +45.6% |
| 7 | Sanofi | 821,917 | $41.3M | 6.6% | 2.8% | 0.0% |
| 8 | D. E. Shaw & Co., Inc. | 819,591 | $41.2M | 0.0% | 2.7% | +51.9% |
| 9 | MILLENNIUM MANAGEMENT LLC | 784,560 | $39.4M | 0.0% | 2.6% | -2.8% |
| 10 | 683 Capital Management, LLC | 740,000 | $37.2M | 1.5% | 2.5% | +12.1% |
| 11 | CITADEL ADVISORS LLC | 650,585 | $32.7M | 0.0% | 2.2% | +65.0% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 639,705 | $32.2M | 0.0% | 2.1% | +0.3% |
| 13 | Palo Alto Investors LP | 595,264 | $29.9M | 4.5% | 2% | -1.4% |
| 14 | Pertento Partners LLPNEW | 545,003 | $27.4M | 1.3% | 1.8% | new |
| 15 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 495,617 | $24.9M | 0.0% | 1.7% | +1.4% |
| 16 | FEDERATED HERMES, INC. | 467,981 | $23.5M | 0.0% | 1.6% | +19.5% |
| 17 | Apis Capital Advisors, LLC | 444,000 | $22.3M | 3.1% | 1.5% | -10.7% |
| 18 | MORGAN STANLEY | 404,164 | $20.3M | 0.0% | 1.4% | +57.2% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 371,647 | $18.7M | 0.0% | 1.2% | -29.6% |
| 20 | JACOBS LEVY EQUITY MANAGEMENT, INC | 352,544 | $17.7M | 0.1% | 1.2% | +465.6% |
| 21 | BANK OF AMERICA CORP /DE/ | 338,518 | $17.0M | 0.0% | 1.1% | -19.0% |
| 22 | Nuveen, LLC | 334,941 | $16.8M | 0.0% | 1.1% | -20.4% |
| 23 | Sofinnova Investments, Inc. | 330,396 | $16.6M | 0.7% | 1.1% | -33.1% |
| 24 | First Light Asset Management, LLC | 328,523 | $16.5M | 1.0% | 1.1% | -43.6% |
| 25 | TWO SIGMA INVESTMENTS, LP | 303,984 | $15.3M | 0.0% | 1% | +15.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.